Why weren't there any big deals announced this week?

What does the word “equivalar” mean? And why is information about prognosis so hard to find?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we recap what happened — and what didn’t — this week at the J.P. Morgan Healthcare Conference in San Francisco. 

Then, we talk about one of the biggest stories of the conference — the launch of a new company called EQRx aiming to develop cheaper medicines — with the health care veteran behind it, Alexis Borisy. 

Finally, we chat with Stephen Buck, the entrepreneur behind a new website called CancerSurvivalRates.com, which is designed to give cancer patients information about their odds of survival.

Listen here.